Source: International Congress 2015 – Respiratory infections: from basic science to clinical issues
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Viktoriya (known as Victoria) Kim (Winchester, United Kingdom), Viktoriya L. Kim, Ngaire A. Coombs, Karl J. Staples, Nicholas P. Williams, Kristoffer Ostridge, Malwina M. Wojtas, Mathieu Peters, Emmanuel Aris, Jeanne-Marie Devaster, Simon C. Bourne, Tom M. Wilkinson. LATE-BREAKING ABSTRACT: Does sputum colour hold the answer? The AERIS study. Eur Respir J 2015; 46: Suppl. 59, 2656

Member's Comments

No comment yet.

Related content which might interest you: LATE-BREAKING ABSTRACT: Eosinophilic inflammation in COPD: During clinical stability and exacerbations. The AERIS study Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Can patients with COPD assimilate disease specific information at a time of being acutely unwell due to an exacerbation of their disease? Source: International Congress 2016 – Best abstracts on innovative outcomes and novel interventions in respiratory physiotherapy Year: 2016 LATE-BREAKING ABSTRACT: An algorithm for the identification of clinical COPD phenotypes in daily practice Source: International Congress 2016 – COPD diagnosis and management Year: 2016 LATE-BREAKING ABSTRACT: The prevalence of night and morning symptoms in primary care COPD patients: How do they relate to COPD health status and disease severity? An UNLOCK study Source: International Congress 2015 – Management of asthma and other respiratory diseases in primary care Year: 2015 LATE-BREAKING ABSTRACT: Stratification of patients with COPD by frequence of exacerbations is an essential step for what to treat in COPD. - A survey in a real life COPD population Source: Annual Congress 2013 –Predictors and triggers of asthma and COPD exacerbations Year: 2013 LATE-BREAKING ABSTRACT: Exacerbation phenotype directed corticosteroid therapy of COPD: Value of blood eosinophilia (primary results) Source: International Congress 2015 – The relevance of diagnostic and monitoring tools in clinical practice Year: 2015 LATE-BREAKING ABSTRACT: Microbiology and radiology of pneumonia in COPD Source: International Congress 2015 – Chronic airway disorders: miscellaneous aspects Year: 2015 LATE-BREAKING ABSTRACT: Tiotropium efficacy and exacerbation risk in patients with different blood eosinophil levels Source: International Congress 2015 – Emerging strategies for airway disease treatments Year: 2015 LATE-BREAKING ABSTRACT: Single inhaler triple therapy (ICS/LAMA/LABA) in patients with advanced COPD: Results of the FULFIL trial Source: International Congress 2016 – Biomarkers and phenotypes of COPD and comorbidities Year: 2016 LATE-BREAKING ABSTRACT: A novel approach for identifying patients with undiagnosed clinically-significant COPD Source: International Congress 2015 – Diagnosing and management of COPD in primary care Year: 2015 LATE-BREAKING ABSTRACT: Validation of the DECAF score to predict hospital mortality in exacerbations of COPD Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 LATE-BREAKING ABSTRACT: Lung function assessed by home forced oscillation and self reported symptoms during COPD exacerbations Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 LATE-BREAKING ABSTRACT: Large differences in rate of reported and unreported COPD exacerbations in Japanese patients; data from the COSMOS-J trial Source: International Congress 2016 – Clinical characteristics of asthma Year: 2016 Are there any differences between Tunisian and European COPD phenotypes? Source: International Congress 2016 – Best abstracts in COPD management Year: 2016 CAT in COPD phenotypes (POPE study) Source: International Congress 2016 – Phenotyping and monitoring airway diseases Year: 2016 What is the best biomarker of COPD stability? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 COPD: GOLD 2011 and implications for clinical practice Source: Annual Congress 2013 –Novel pharmacological findings in the management of respiratory disorders Year: 2013 Can we consider the "frequent exacerbator" a reliable COPD phenotype? Source: International Congress 2015 – COPD: chronic disease and comorbidities Year: 2015 Implications of under treatment of stable COPD (SAVING study) Source: International Congress 2015 – New data on established treatments for COPD Year: 2015 LATE-BREAKING ABSTRACT: Evaluating blood eosinophils and exacerbation history to predict ICS response in COPD Source: International Congress 2016 – Late-breaking topics in airways disease Year: 2016